| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/01/2010 | US20100166741 Altered br-3 binding polypeptides |
| 07/01/2010 | US20100166740 contains a Fc part derived from human origin; does not bind complement factor C1q; antiinflammatory, antiarthritic, antihistamine and bronchodilator agents; asthma treatment; gene expression |
| 07/01/2010 | US20100166739 Methods and Compositions for Diagnosing Urological Disorders |
| 07/01/2010 | US20100166738 Compositions and methods for wt1 specific immunotherapy |
| 07/01/2010 | US20100166737 P38Alpha as a Therapeutic Target in Bladder Carcinoma |
| 07/01/2010 | US20100166736 Immunostimulatory oligonucleotide multimers |
| 07/01/2010 | US20100166735 Methods and compositions for reduction of side effects of therapeutic treatments |
| 07/01/2010 | US20100166734 Oral delivery of polypeptides |
| 07/01/2010 | US20100166733 Mcp-1 splice variants and methods of using same |
| 07/01/2010 | US20100166732 Small streptococcus pyogenes antigens and their use |
| 07/01/2010 | US20100166731 Methods and Compositions for Treating Cancer |
| 07/01/2010 | US20100166705 Culturing circular ssDNA viruses for the production of vaccines |
| 07/01/2010 | US20100166704 Methods and compositions for inhibition of viral replication |
| 07/01/2010 | US20100166703 Use of il-6/il-6 chimera in huntington's disease |
| 07/01/2010 | US20100166700 Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates and Their Preparation |
| 07/01/2010 | US20100166699 Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators |
| 07/01/2010 | US20100166698 New compositions and methods for the treatment of inflammation |
| 07/01/2010 | US20100166675 Pharmaceutical Composition for the Treatment of Type 1-Diabetes |
| 07/01/2010 | US20100166652 Laminin receptor 1 precursor protein (37LRP) epitope delineated by an hepatocellular carcinoma specific antibody |
| 07/01/2010 | US20100166649 Method to inhibit cancer targeting cd24 |
| 07/01/2010 | CA2748990A1 Diagnosis and treatment of cancer using anti-lgr7 antibody |
| 07/01/2010 | CA2748161A1 Targeted binding agents directed to .alpha.5.beta.1 and uses thereof |
| 07/01/2010 | CA2748158A1 Targeted binding agents directed to .alpha.5.beta.1 and uses thereof |
| 07/01/2010 | CA2748149A1 Modified steptococcus pneumonia pneumolysin (ply) polypeptides |
| 07/01/2010 | CA2748069A1 Stable pharmaceutical composition containing at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents |
| 07/01/2010 | CA2748038A1 Method for inducing a trif-bias |
| 07/01/2010 | CA2747938A1 Immunostimulating saponins for use in in situ tumor-destruction therapy |
| 07/01/2010 | CA2747686A1 C1orf59 peptides and vaccines including the same |
| 07/01/2010 | CA2747326A1 Combination of aurora kinase inhibitors and anti-cd20 antibodies |
| 07/01/2010 | CA2747206A1 Pain treatment |
| 07/01/2010 | CA2746942A1 Ex-vivo passive protection bacteremia assay |
| 07/01/2010 | CA2746827A1 Osteoarthritis treatment |
| 07/01/2010 | CA2746330A1 Immunoglobulin variants with altered binding to protein a |
| 07/01/2010 | CA2746009A1 Single recombination system and methods of use |
| 07/01/2010 | CA2745707A1 Immunoglobulin purification |
| 07/01/2010 | CA2745317A1 Antibodies against tissue factor pathway inhibitor |
| 06/30/2010 | EP2202315A1 Modified vaccinia ankara virus variant |
| 06/30/2010 | EP2202298A1 Recombinant classical swine fever virus (CSFV) comprising a modified E2 protein and methods for generating said recombinant CSFV |
| 06/30/2010 | EP2202297A1 Use of a chemotherapeutic agent in the preparation of a medicament for treating or ameliorating an adverse side effect associated with oncolytic viral therapy |
| 06/30/2010 | EP2202245A1 Method of modifying isoelectric point of antibody via amino acid substitution in cdr |
| 06/30/2010 | EP2202243A2 Antigen binding domains from fish |
| 06/30/2010 | EP2201961A1 Immunogenic composition |
| 06/30/2010 | EP2201959A2 Use of IL-12 and IL-12 antagonists for the manufacture of a pharmaceutical composition for the treatment of autoimmune diseases |
| 06/30/2010 | EP2201117A2 Extracellular targets for alzheimer's disease |
| 06/30/2010 | EP2201109A1 Truncated secretory aspartyl proteinase 2 |
| 06/30/2010 | EP2201103A2 Treatment of tumours using t lymphocyte preparations |
| 06/30/2010 | EP2201040A1 Monoclonal antibodies to respiratory syncytial virus and uses thereof |
| 06/30/2010 | EP2201031A1 Hypoallergenic variants of the major allergen from betula verrucosa pollen |
| 06/30/2010 | EP2201026A1 Novel p2x7 epitopes |
| 06/30/2010 | EP2200649A2 Compositions and methods for ameliorating cns inflammation, psychosis, delirium, ptsd or ptss |
| 06/30/2010 | EP2200648A1 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects |
| 06/30/2010 | EP2200647A1 Antibodies specific for human hepcidin |
| 06/30/2010 | EP2200642A1 Meningococcal vaccine formulations |
| 06/30/2010 | EP2200641A1 Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis |
| 06/30/2010 | EP2200640A1 Attenuated mycoplasma gallisepticum strains |
| 06/30/2010 | EP2200639A2 Immunostimulatory combinations of tlr3 ligands with tlr2 and/or tlr9 agonists and methods of use |
| 06/30/2010 | EP2200637A2 Long interspersed nuclear element polypeptide compositions and methods of use thereof |
| 06/30/2010 | EP2200636A1 Protein |
| 06/30/2010 | EP2200601A1 Blockers of serotonin and its receptors for the treatment of hepatitis |
| 06/30/2010 | EP1689433B1 Compositions and methods for activating innate and allergic immunity |
| 06/30/2010 | EP1622648B1 Dna vaccines against tumor growth and methods of use thereof |
| 06/30/2010 | EP1578799B1 Antibodies directed to tumor necrosis factor and uses thereof |
| 06/30/2010 | EP1516881B1 Composition and method for modulating dendritic Cell-T cell interaction |
| 06/30/2010 | EP1399183B1 Chimeric alphavirus replicon particles |
| 06/30/2010 | EP1332366B1 Methods for the Assessment of Cellular Proliferative Disorders |
| 06/30/2010 | CN1821407B High efficiency stable expression system of transgene tomato |
| 06/30/2010 | CN101765610A Novel immunogenic epitopes for immunotherapy |
| 06/30/2010 | CN101765607A HPV epitopes targeted by t cells infiltrating cervical malignancies for use in vaccines |
| 06/30/2010 | CN101765434A Composition of tumour-associated peptides and related anti-cancer vaccine |
| 06/30/2010 | CN101759804A Anti-human thyroglobulin monoclonal antibody and application thereof |
| 06/30/2010 | CN101757620A Inactivated vaccine for avian infectious bronchitis and preparation method thereof |
| 06/30/2010 | CN101757619A Veterinary rabies inactivated vaccine and preparation method thereof |
| 06/30/2010 | CN101757618A Recombined subunit vaccine of haemaphysalis concinna and preparation method thereof |
| 06/30/2010 | CN101199861B DNA vaccine for resisting liver cancer |
| 06/30/2010 | CN101130072B Type A inactivated vaccine for hoof-and-mouth disease |
| 06/29/2010 | US7745593 Feline CTLA-4 nucleic acid and polypeptides |
| 06/29/2010 | US7745587 comprising heavy chain and light chain immunoglobulin variable domain sequences; (complementary determining regions) CDR/antibodies, used to treat or prevent metastasis, hyperproliferation, inflammation and disorders characterized by excessive extracellular matrix degradation; enzyme inhibitors |
| 06/29/2010 | US7745585 humanized, chimeric, genetic engineered, monoclonal or polyclonal antibody, or fragment, useful in the therapy of cancer, fibrosis and chronic obstructive pulmonary disease |
| 06/29/2010 | US7745582 Purification of immunoglobulins from solution (hybridoma cell culture supernatants, animal plasma or sera, or colostrum); solid phase synthesis |
| 06/29/2010 | US7745581 T-bet compositions and methods of use thereof |
| 06/29/2010 | US7745580 polypeptide comprising an amino acid sequence that comprises lymphoctye epitopes and is capable of inducing an immune response against a molecule expressed on the surface of an intact erythrocyte infected by a placental parasite; vaccines |
| 06/29/2010 | US7745410 Bladder tumor-targeting peptide and use thereof |
| 06/29/2010 | US7745406 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders |
| 06/29/2010 | US7745397 Containing one or more epitopes recognized by and binding to a BAT monoclonal antibody; cancer vaccines |
| 06/29/2010 | US7745395 Recombinant protease comprising prostate-specific protease cleavage site and deficient in furin cleavage site for use as therapeutic agent in treatment of cell proliferative disorders; antitumor agents |
| 06/29/2010 | US7745394 Antibody-drug conjugates; Auristatin peptides, including MeVal-Val-Dil-Dap-Norephedrine (MMAE) and MeVal-Val-Dil-Dap-Phe (MMAF); cancer; autoimmune diseases |
| 06/29/2010 | US7745217 Graft prosthesis devices containing renal capsule collagen |
| 06/29/2010 | US7745212 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 06/29/2010 | US7745193 recombinant nucleotide sequence which codes upon expression for at least a part of a bifunctional hybrid active-site serine beta -lactamase protein |
| 06/29/2010 | US7745165 Calibration of colorectal cancer; gene expression profile; administering to human an antibody which binds to protein markers |
| 06/29/2010 | US7745159 Using presence and concentration of mesothelin related antigen (MRA) to detect and prognose tumors; antitumor agents |
| 06/29/2010 | US7745157 Enhancing an immune response to an antigen in a mammal by administering lymphocyte conditioned median based on a mixture of cytokines and chemokines obtained from peripheral blood mononuclear cells stimulated with antiCD3/CD28-coated beads; used with traditional vaccines or cancer immunotherapy |
| 06/29/2010 | US7745156 Methods for diagnosis and treatment of epithelial-derived cancers |
| 06/29/2010 | US7745141 Using early presence of tubercular signal transduction protein as diagnostic/prognostic indicator of tuberculosis; bioassay |
| 06/29/2010 | US7745139 for eliminating specifically binding, cell-physiologically active, pathological antibodies in preeclampsia and malign hypertension |
| 06/29/2010 | US7745114 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 06/29/2010 | US7744907 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method |
| 06/29/2010 | US7744906 Chaperone proteins comprising at least one of three specific nucleotide sequences; analgesics; side effect reduction; lastslonger than narcotics; relieving any type of pain |
| 06/29/2010 | US7744905 Immunogenic polypeptide isolated from mycobacterium avium subspecies paratuberculosis and uses thereof |
| 06/29/2010 | US7744904 Stabilization of Clostridium botulinum neurotoxin complex |